How it works
What's the Cost of Fibrocystic breast disease Diagnosis and Treatment in Republic of Korea?
Best Fibrocystic breast disease Treatment Centers in Republic of Korea: 6 Verified Options and Prices
Ewha Womans University Medical Center
Paik Nam-sun






Get a Medical Assessment for Fibrocystic breast disease in Republic of Korea: Consult with Experienced Doctors Now
View all Doctors
Shin Hyuk Jai
Dr. Hyuk‑Jai Shin, MD, PhD, is a Clinical Professor of Surgery at Myongji Hospital in South Korea. He is also Director of the Breast Center and Vice President for Medical Affairs. His work focuses on breast cancer, benign breast disease, robotic and endoscopic breast surgery, and systemic therapy. He chairs the Korean Breast Cancer Society group for robotic and endoscopic minimally invasive surgery. He is a full member of ASCO.
He earned his MD and PhD from Dankook University. He completed a breast fellowship and served as a principal proteomics researcher at Seoul National University Hospital. He received endoscopic training at Kameda Hospital in Japan. He was an exchange professor at the University of Melbourne and a visiting surgeon at the Peter MacCallum Cancer Centre. He previously led the Breast & Thyroid Center and the Precision Medicine Center at Myongji Hospital. His publications include first‑author chapters in Translational Research in Breast Cancer (Chapter 30, pp. 567–590, Springer) and the Textbook of Surgical Ultrasound (Chapter 3‑3, VABB). He also co‑authored a nationwide VABB survey (Anticancer Research, 2012; 32(12):5459–64).

Lee Jihyeon
Dr. Lee Jihyeon is a breast and thyroid surgeon. He has expertise in benign and malignant breast diseases, oncoplastic breast surgery, and Mammotome biopsy. He also treats thyroid and parathyroid diseases. He practices pulmonary intensive care (critical care medicine).
He earned his M.D. from Yonsei University College of Medicine. He completed an internship and a general surgery residency at Yonsei University Severance Hospital. He also pursued a short-term fellowship at the Cancer Institute Hospital of JFCR in Japan.
His past roles include Chief of Surgery at Incheon Christian Hospital and Attending Surgeon at Cheil General Hospital. He served as Director of the Breast Center and as Chairman and Chief of Surgery at Samsung Cheil Hospital. He was Chairman of Surgery and Vice President of Medical Affairs at Cheil General Hospital. He also served as Clinical Professor of Surgery at Gangnam CHA Hospital, CHA University.

Kim Wan Song
Dr. Wan‑Sung Kim, MD, PhD, is Director of the Thyroid Center and an Associate Professor of Surgery at Myongji Hospital, an educational partner of Hanyang University. He is a breast and thyroid surgeon. He treats cancer and benign disease and focuses on minimally invasive thyroid and adrenal surgery.
Expertise: endoscopic and robotic thyroidectomy (transoral, axillary-areolar), thyroid radiofrequency ablation, ethanol ablation for thyroid lesions, and endoscopic or robotic adrenal tumor surgery.
He previously served as Head of Surgery at Myongji Hospital and Chuncheon Gangnam Hospital. He completed his residency and a breast and thyroid fellowship at Myongji. He holds an MD and MS from Catholic Kwandong University and a PhD from Kangwon National University. He is a member of the Korean Association of Thyroid and Endocrine Surgeons, the Korean Breast Cancer Society, the Korean Surgical Society, and the Korean Surgical Ultrasound Society.

Paik Nam-sun
Dr. Paik Nam-sun is a surgical oncologist at Ewha Womans University Medical Center in Seoul. He is recognized as one of the world's top 100 gastric and breast cancer surgeons. He performed the first breast-conserving surgery in South Korea. Dr. Paik also invented a proprietary stomach cancer technique to reduce reflux disease risk.
- Director of the Cancer Center for Women at Ewha Womans University Medical Center.
- Former President of Konkuk University Hospital.
- Served as the Director of the Korea Cancer Center Hospital.
- Former President of the Korean Society of Cancer Prevention.
Reviews about Bookimed: Discover Patients' Insights
All reviews



Share this content
Video Stories from Bookimed Patients
Anna Leonova
Expert Overview about Fibrocystic breast disease Treatment in Republic of Korea
Do I need surgery for lumpy, painful breasts in Korea?
Surgery for lumpy breasts in Korea is not always required. Specialists primarily use surgery to remove symptomatic benign tumors or suspicious masses. Most fibrocystic changes are managed through monitoring and imaging. Minimal incision techniques like Vacuum-Assisted Biopsy (VABB) allow for simultaneous diagnosis and treatment.
- Diagnostic priority: Doctors use mammography and ultrasound to distinguish benign cysts from concerning masses.
- Surgical criteria: Removal is typically recommended for lumps exceeding 3cm or those causing pain.
- Minimally invasive: Korean centers often utilize 4mm incisions to minimize scarring during tumor excision.
- Specialized facilities: Dedicated women clinics like Ewha Womans University Medical Center focus on aesthetic outcomes.
Bookimed Expert Insight: Korea excels in digital diagnostics for dense breast tissue. Hospitals like Seoul National University Bundang Hospital use advanced AI and digital imaging systems. This technology helps avoid unnecessary surgeries by providing higher accuracy in identifying benign fibrocystic patterns. Patients should prioritize clinics with integrated breast centers for seamless transition from imaging to biopsy.
Patient Consensus: Patients note that lumpy breasts often feel more alarming than they are. They emphasize getting professional imaging at specialized centers like Severance Hospital to distinguish between simple cysts and tissue that requires a biopsy.
Does having fibrocystic breasts mean I have a higher risk of breast cancer?”
Having fibrocystic breasts generally does not increase your breast cancer risk. This common condition is benign and non-cancerous. However, lumpy tissue can occasionally mask small tumors during screenings. Detection relies on comparing baseline texture changes with any new or persistent findings during imaging.
- Condition nature: Fibrocystic changes are benign physiological patterns, not a disease.
- Screening difficulty: Denser tissue may require both mammography and ultrasound for clarity.
- Family history: Risk may slightly increase if combined with a strong family history.
- Digital imaging: South Korean hospitals like Severance use digital systems for high-resolution breast screening.
Bookimed Expert Insight: Advanced digital diagnostic systems in Korea significantly reduce human error when screening dense or fibrocystic breasts. For instance, Seoul National University Bundang Hospital uses the BESTcare system specifically to improve diagnostic accuracy. If you have persistent lumpy tissue, choosing a clinic like Ewha Womans University Medical Center is wise because they specialize specifically in women's health and aesthetic-focused diagnostic results.
Patient Consensus: Patients note that the term sounds scarier than it is. Most feel relieved after receiving same-day ultrasound and mammography results that confirm their lumps are purely fibrocystic.
What kinds of treatment are commonly performed in Korean clinics for fibrocystic breasts?
Korean clinics treat fibrocystic breasts through symptom management and advanced diagnostic monitoring. Facilities in Seoul and Incheon utilize high-resolution ultrasound and digital imaging to track hormonal changes. Common procedures include ultrasound-guided fine-needle aspiration for painful cysts and conservative medication management to reduce breast tenderness.
- Diagnostic imaging: Specialized centers use ultrasound and mammography to monitor non-precancerous tissue changes.
- Cyst aspiration: Doctors perform ultrasound-guided fine-needle aspiration to drain fluid and relieve pressure.
- Medication management: Clinicians prescribe anti-inflammatory drugs or hormonal treatments to alleviate cyclic pain.
- Expert monitoring: JCI-accredited hospitals provide regular screenings to distinguish benign changes from masses.
Bookimed Expert Insight: South Korea is a leader in women-only medical care, with centers like Ewha Womans University Medical Center focusing specifically on female-centric diagnostics. Our data shows these specialized centers prioritize aesthetic outcomes and minimal scarring, which is crucial if a biopsy becomes necessary to confirm benign fibrocystic changes.
Patient Consensus: Patients note that Korean specialists are thorough, often providing same-day imaging and translated results. Many emphasize that doctors here focus on providing clarity and reducing anxiety by clearly distinguishing normal hormonal changes from tumors.
When should I definitely see a doctor in Korea for fibrocystic-related symptoms?
Consult a doctor in Korea if breast lumps persist after your menstrual cycle. Seek immediate evaluation for bloody nipple discharge, skin dimpling, or new nipple inversion. Specialized centers like Ewha Womans University Medical Center provide diagnostic mammography and ultrasound to distinguish benign fibrocystic changes from serious conditions.
- New lumps: Visit a specialist if lumps feel hard or fixed.
- Persistent pain: See a doctor for severe pain that ignores cycles.
- Skin changes: Check for redness, puckering, or an orange-peel texture immediately.
- Post-menopause symptoms: Any new breast symptoms after menopause require urgent clinical screening.
Bookimed Expert Insight: Korea's medical landscape offers a unique advantage for women's health through gender-specific hospitals. Ewha Womans University Medical Center functions as a women-only facility. Our data shows it maintains JCI and KOIHA accreditations. This environment often reduces the anxiety patients feel during invasive diagnostic breast exams or biopsies.
Patient Consensus: Patients note it is vital to get checked if a lump feels different from usual monthly soreness. They emphasize that professional imaging in Korea often provides much-needed reassurance when home results are unclear.













